Neurocrine Biosciences holds the cleaner structural position, with the lead spread across valuation and stability. The remaining gap is narrow enough that the comparison remains open to different readings. The market setup broadly confirms the structural lead — Neurocrine Biosciences holds the more constructive position. That puts structure and market broadly in agreement — Neurocrine Biosciences's lead looks more confirmed than conflicted.
The comparison is based on similar long-term financial trajectories, not sector labels. Both peer scores are relative to the Russell 1000 universe, making them directly comparable.
The lead is spread across valuation and stability, rather than sitting in one isolated gap. Neurocrine Biosciences, Inc. leads by 8 points on the overall comparison score.
This pair is matched through long-term financial trajectory similarity within the selected peer universe.
This level of similarity signals a strong structural match, even though some dimensions still separate the two companies.
The clearest structural overlap shows up in capital structure and revenue stability.
Scores reflect position relative to comparable companies with similar long-term financial trajectories.
Score differences across key dimensions.
Left means cheaper relative valuation. Higher means stronger structure.
Neurocrine Biosciences, Inc. and Stryker Corporation look relatively close on structure, but the price setup still leans toward Neurocrine Biosciences, Inc..
Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.
Where NBIX and SYK each sit in their own 5-year price and valuation history.
Describes historical entry positioning only. Descriptive — not investment advice.
The multiple-based pricing edge comes from a forward P/E that is 7.5 turns lower.
Stability adds another layer of support rather than leaving the result tied to valuation alone.
The lead is built on both valuation and stability, making it broader than a single-dimension result.
Break down the NBIX vs SYK comparison across all dimensions with the full interactive tool.
Explore how NBIX and SYK each compare against other companies in their peer groups.
Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.
AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.
Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.
Because scores are peer-relative, the same company can have slightly different scores in different index universes. On comparison pages, both companies are shown within their shared peer universe wherever possible — so the scores are directly comparable. The peer basis is stated on each score card.
Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.